Evaluation of anti-HIV agents in vitro by quantitative PCR.
Joshi
B
B
Laboratory of Retrovirology, Food and Drug Administration, Bethesda, Maryland 20892.
Epstein
J
J
Lee
S F
SF
Mayner
R
R
Hewlett
I K
IK
D002460:Cell Line; D004338:Drug Combinations; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000494:pharmacology*; D016133:Polymerase Chain Reaction / Q000379:methods*; D011994:Recombinant Proteins; D015215:Zidovudine / Q000494:pharmacology*
D004338:Drug Combinations; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D015215:Zidovudine